JP2014500323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500323A5 JP2014500323A5 JP2013546270A JP2013546270A JP2014500323A5 JP 2014500323 A5 JP2014500323 A5 JP 2014500323A5 JP 2013546270 A JP2013546270 A JP 2013546270A JP 2013546270 A JP2013546270 A JP 2013546270A JP 2014500323 A5 JP2014500323 A5 JP 2014500323A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- carbonyl
- acid
- substituted
- chlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 47
- 229910052799 carbon Inorganic materials 0.000 claims 25
- 150000001721 carbon Chemical group 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 21
- 125000005843 halogen group Chemical group 0.000 claims 20
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 19
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 19
- 125000004093 cyano group Chemical group *C#N 0.000 claims 18
- 229910052757 nitrogen Inorganic materials 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 16
- -1 C 1 -C 3 alkyl Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 12
- 239000002253 acid Substances 0.000 claims 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 11
- 125000005842 heteroatom Chemical group 0.000 claims 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 10
- 125000001153 fluoro group Chemical group F* 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 125000004076 pyridyl group Chemical group 0.000 claims 8
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 4
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 claims 2
- 125000006661 (C4-C6) heterocyclic group Chemical group 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- AHULTIIBEPSESW-XMMPIXPASA-N 5-[7-[[(1r)-6-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=C(F)C=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 AHULTIIBEPSESW-XMMPIXPASA-N 0.000 claims 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- PLEHSLVXSJBCKV-UHFFFAOYSA-N 1-methylspiro[2h-indole-3,4'-piperidine] Chemical compound C12=CC=CC=C2N(C)CC21CCNCC2 PLEHSLVXSJBCKV-UHFFFAOYSA-N 0.000 claims 1
- CKUIIYFYSJOMEB-UHFFFAOYSA-N 2-[2-[3-phenyl-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]ethyl]cyclopropane-1-carboxylic acid Chemical compound OC(=O)C1CC1CCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 CKUIIYFYSJOMEB-UHFFFAOYSA-N 0.000 claims 1
- ATCZSYWQJLLZQT-HXUWFJFHSA-N 2-[3-[2-[3-(4-chlorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]ethyl]phenyl]acetic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=2)=CC=C1N=C(C=1C=CC(Cl)=CC=1)C=2CCC1=CC=CC(CC(O)=O)=C1 ATCZSYWQJLLZQT-HXUWFJFHSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- HBOHHMXJFJZJFP-UHFFFAOYSA-N 2-methyl-5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethyl)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)C=C1 HBOHHMXJFJZJFP-UHFFFAOYSA-N 0.000 claims 1
- FCMHMWSISMADQK-HSZRJFAPSA-N 4-[[3-phenyl-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]amino]butanoic acid Chemical compound OC(=O)CCCNC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 FCMHMWSISMADQK-HSZRJFAPSA-N 0.000 claims 1
- YLGGKIXDLNCBDG-UHFFFAOYSA-N 4-[[7-[4-(4-fluorophenyl)piperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]amino]butanoic acid Chemical compound OC(=O)CCCNC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 YLGGKIXDLNCBDG-UHFFFAOYSA-N 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- UXVXQIXXRFWEHY-UHFFFAOYSA-N 5-[3-(2,4-dichlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1Cl UXVXQIXXRFWEHY-UHFFFAOYSA-N 0.000 claims 1
- GTYULXMAFRIULP-UHFFFAOYSA-N 5-[3-(2-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1Cl GTYULXMAFRIULP-UHFFFAOYSA-N 0.000 claims 1
- LYSLGIYLHAJKNV-UHFFFAOYSA-N 5-[3-(3-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC(Cl)=C1 LYSLGIYLHAJKNV-UHFFFAOYSA-N 0.000 claims 1
- NJVVDPIZJKMBBV-UHFFFAOYSA-N 5-[3-(3-fluorophenyl)-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC(F)=C1 NJVVDPIZJKMBBV-UHFFFAOYSA-N 0.000 claims 1
- ZCHFLTJXTZIDBK-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(3-oxospiro[2,4-dihydroisoquinoline-1,4'-piperidine]-1'-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C3=CC=CC=C3CC(=O)N4)=CC=C2N=C1C1=CC=C(Cl)C=C1 ZCHFLTJXTZIDBK-UHFFFAOYSA-N 0.000 claims 1
- WVYXGMXYFUDADF-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 WVYXGMXYFUDADF-UHFFFAOYSA-N 0.000 claims 1
- NITJHYGVFOXRNS-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 NITJHYGVFOXRNS-UHFFFAOYSA-N 0.000 claims 1
- UGXDYFAJDDBFQB-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 UGXDYFAJDDBFQB-UHFFFAOYSA-N 0.000 claims 1
- SRUXDYWXCHAAGK-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 SRUXDYWXCHAAGK-UHFFFAOYSA-N 0.000 claims 1
- ABUWKLSZDNQAPT-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(3-chlorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 ABUWKLSZDNQAPT-UHFFFAOYSA-N 0.000 claims 1
- DKHCNCMNAWJEAR-DEOSSOPVSA-N 5-[3-(4-chlorophenyl)-7-[(3r)-3-phenylpiperidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C[C@H](CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 DKHCNCMNAWJEAR-DEOSSOPVSA-N 0.000 claims 1
- NGLZCDGNGNQGTC-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-chlorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 NGLZCDGNGNQGTC-UHFFFAOYSA-N 0.000 claims 1
- JLBOYXNHRJDIOI-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-cyanophenyl)methylcarbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=C(Cl)C=C1 JLBOYXNHRJDIOI-UHFFFAOYSA-N 0.000 claims 1
- NJMWDGMQZOCRLR-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-cyanophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=C(Cl)C=C1 NJMWDGMQZOCRLR-UHFFFAOYSA-N 0.000 claims 1
- VPUHVGZKBQZBCQ-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-fluorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 VPUHVGZKBQZBCQ-UHFFFAOYSA-N 0.000 claims 1
- OTGJKOCMFDWBSY-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-methylphenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC(Cl)=CC=3)C2=C1 OTGJKOCMFDWBSY-UHFFFAOYSA-N 0.000 claims 1
- FJZRMJPPNHAQHW-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[3-(4-chlorophenyl)azetidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 FJZRMJPPNHAQHW-UHFFFAOYSA-N 0.000 claims 1
- WTSCOWYNIMHQMR-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[4-(2,6-dimethylphenyl)piperazine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound CC1=CC=CC(C)=C1N1CCN(C(=O)C=2C=C3N=C(CCCCC(O)=O)C(=NC3=CC=2)C=2C=CC(Cl)=CC=2)CC1 WTSCOWYNIMHQMR-UHFFFAOYSA-N 0.000 claims 1
- WSGSQWFAXNIQAN-MRXNPFEDSA-N 5-[3-(4-chlorophenyl)-7-[[(1r)-1-(3,5-difluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=C(F)C=C(F)C=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 WSGSQWFAXNIQAN-MRXNPFEDSA-N 0.000 claims 1
- LUHSVHVYLKBSFI-QGZVFWFLSA-N 5-[3-(4-chlorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 LUHSVHVYLKBSFI-QGZVFWFLSA-N 0.000 claims 1
- OAZRQIRRMIRDQK-INIZCTEOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(3,4-difluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=C(F)C(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 OAZRQIRRMIRDQK-INIZCTEOSA-N 0.000 claims 1
- ZFJBYRNIBUAPIZ-ZVAWYAOSSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N[C@@H](C)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 ZFJBYRNIBUAPIZ-ZVAWYAOSSA-N 0.000 claims 1
- OFQDLPFZBWUVFT-KRWDZBQOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 OFQDLPFZBWUVFT-KRWDZBQOSA-N 0.000 claims 1
- YGLXTOGDGBRMCU-ZVAWYAOSSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@@H](C)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 YGLXTOGDGBRMCU-ZVAWYAOSSA-N 0.000 claims 1
- LUHSVHVYLKBSFI-KRWDZBQOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 LUHSVHVYLKBSFI-KRWDZBQOSA-N 0.000 claims 1
- FSHWGGMDSFJDMP-SANMLTNESA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC(F)=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 FSHWGGMDSFJDMP-SANMLTNESA-N 0.000 claims 1
- VHDSRXYQUVZRQE-KKFPZRRJSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 VHDSRXYQUVZRQE-KKFPZRRJSA-N 0.000 claims 1
- UICRIQGBCJEJOV-LYTHVRBOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 UICRIQGBCJEJOV-LYTHVRBOSA-N 0.000 claims 1
- PMRMAQMOQKTSPA-SANMLTNESA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 PMRMAQMOQKTSPA-SANMLTNESA-N 0.000 claims 1
- QHPMRURREYGFPL-QFIPXVFZSA-N 5-[3-(4-chlorophenyl)-7-[[(4s)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=C(Cl)C=C1 QHPMRURREYGFPL-QFIPXVFZSA-N 0.000 claims 1
- YFEDJXVZDTWTNQ-UHFFFAOYSA-N 5-[3-(4-cyanophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C#N)C=C1 YFEDJXVZDTWTNQ-UHFFFAOYSA-N 0.000 claims 1
- YXXSTFZHHVEZRL-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 YXXSTFZHHVEZRL-UHFFFAOYSA-N 0.000 claims 1
- XVMNNQVVFSVODZ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C(NCN4C=3C=CC=CC=3)=O)=CC=C2N=C1C1=CC=C(F)C=C1 XVMNNQVVFSVODZ-UHFFFAOYSA-N 0.000 claims 1
- BIROENSSMJMMMJ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenyl-3,6-dihydro-2h-pyridine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC=C(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 BIROENSSMJMMMJ-UHFFFAOYSA-N 0.000 claims 1
- JQNFVAHCXSPKMC-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 JQNFVAHCXSPKMC-UHFFFAOYSA-N 0.000 claims 1
- MALHGOATKFJPPJ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 MALHGOATKFJPPJ-UHFFFAOYSA-N 0.000 claims 1
- UUXJVLABONBKOF-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-[(4-fluorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 UUXJVLABONBKOF-UHFFFAOYSA-N 0.000 claims 1
- NGVRTHJIKOSOBD-XMMPIXPASA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=C(F)C=C1 NGVRTHJIKOSOBD-XMMPIXPASA-N 0.000 claims 1
- YOPMYGRFLYGECV-QGZVFWFLSA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 YOPMYGRFLYGECV-QGZVFWFLSA-N 0.000 claims 1
- KAZALQJIEBKPSI-GOSISDBHSA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 KAZALQJIEBKPSI-GOSISDBHSA-N 0.000 claims 1
- YOPMYGRFLYGECV-KRWDZBQOSA-N 5-[3-(4-fluorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 YOPMYGRFLYGECV-KRWDZBQOSA-N 0.000 claims 1
- GGDXRZWHYZBKED-SANMLTNESA-N 5-[3-(4-fluorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(F)C=C1 GGDXRZWHYZBKED-SANMLTNESA-N 0.000 claims 1
- CYTUDLXZTPNEKI-UHFFFAOYSA-N 5-[3-(4-methoxyphenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C(=O)N3CCC(CC3)C=3C=CC=CC=3)C=C2N=C1CCCCC(O)=O CYTUDLXZTPNEKI-UHFFFAOYSA-N 0.000 claims 1
- HKCRZXOFAORWSD-UHFFFAOYSA-N 5-[3-phenyl-7-(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 HKCRZXOFAORWSD-UHFFFAOYSA-N 0.000 claims 1
- BYTLKLSTJRGUEP-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C(CCCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 BYTLKLSTJRGUEP-UHFFFAOYSA-N 0.000 claims 1
- IHZAWJISSKJQOT-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpropan-2-ylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound C=1C=CC=CC=1C(C)(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IHZAWJISSKJQOT-UHFFFAOYSA-N 0.000 claims 1
- OPZZPKKKIDQHRU-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C(CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 OPZZPKKKIDQHRU-UHFFFAOYSA-N 0.000 claims 1
- UGYYZNUOFYQKBG-UHFFFAOYSA-N 5-[3-phenyl-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 UGYYZNUOFYQKBG-UHFFFAOYSA-N 0.000 claims 1
- AGAZDQBVISMZRB-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperazine-1-carbonyl)pyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CN=C2N=C1C1=CC=CC=C1 AGAZDQBVISMZRB-UHFFFAOYSA-N 0.000 claims 1
- SPQAZOCLKUDXER-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 SPQAZOCLKUDXER-UHFFFAOYSA-N 0.000 claims 1
- AKOURSCLEDYGNA-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 AKOURSCLEDYGNA-UHFFFAOYSA-N 0.000 claims 1
- WQWGONUPESCXRS-UHFFFAOYSA-N 5-[3-phenyl-7-(4-pyrazin-2-ylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3N=CC=NC=3)=CC=C2N=C1C1=CC=CC=C1 WQWGONUPESCXRS-UHFFFAOYSA-N 0.000 claims 1
- KHLZAFFKSHZTBQ-UHFFFAOYSA-N 5-[3-phenyl-7-(piperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCCCC3)=CC=C2N=C1C1=CC=CC=C1 KHLZAFFKSHZTBQ-UHFFFAOYSA-N 0.000 claims 1
- NGHJLIPGPGHZHE-UHFFFAOYSA-N 5-[3-phenyl-7-(pyridin-2-ylmethylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 NGHJLIPGPGHZHE-UHFFFAOYSA-N 0.000 claims 1
- WZMCCCJFXLKKKQ-UHFFFAOYSA-N 5-[3-phenyl-7-(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(C5=CC=CC=C5CC4)CC3)=CC=C2N=C1C1=CC=CC=C1 WZMCCCJFXLKKKQ-UHFFFAOYSA-N 0.000 claims 1
- CJQMKUBFNZYSKT-VWLOTQADSA-N 5-[3-phenyl-7-[(3r)-3-phenylpiperidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C[C@H](CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 CJQMKUBFNZYSKT-VWLOTQADSA-N 0.000 claims 1
- BMSPMPQKQBLZAS-UHFFFAOYSA-N 5-[3-phenyl-7-[1-[4-(trifluoromethoxy)phenyl]ethylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound C=1C=C(OC(F)(F)F)C=CC=1C(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 BMSPMPQKQBLZAS-UHFFFAOYSA-N 0.000 claims 1
- HKCRZXOFAORWSD-XMMPIXPASA-N 5-[3-phenyl-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 HKCRZXOFAORWSD-XMMPIXPASA-N 0.000 claims 1
- IWQFMQWAUOIELK-LJQANCHMSA-N 5-[3-phenyl-7-[[(1r)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IWQFMQWAUOIELK-LJQANCHMSA-N 0.000 claims 1
- IWQFMQWAUOIELK-IBGZPJMESA-N 5-[3-phenyl-7-[[(1s)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IWQFMQWAUOIELK-IBGZPJMESA-N 0.000 claims 1
- ALJNBCVUKTYCGW-UHFFFAOYSA-N 5-[3-phenyl-7-[[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC(C=3C=CC(F)=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=CC=C1 ALJNBCVUKTYCGW-UHFFFAOYSA-N 0.000 claims 1
- BJVXOISGHHEPQP-UHFFFAOYSA-N 5-[3-phenyl-7-[[4-(trifluoromethyl)phenyl]methylcarbamoyl]pyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C(F)(F)F)=CN=C2N=C1C1=CC=CC=C1 BJVXOISGHHEPQP-UHFFFAOYSA-N 0.000 claims 1
- JQBAXPWYUTYXGO-UHFFFAOYSA-N 5-[3-phenyl-7-[[4-(trifluoromethyl)phenyl]methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=CC=C1 JQBAXPWYUTYXGO-UHFFFAOYSA-N 0.000 claims 1
- ZWCNNSKSVCPUJA-UHFFFAOYSA-N 5-[7-(1-acetylspiro[2h-indole-3,4'-piperidine]-1'-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C12=CC=CC=C2N(C(=O)C)CC1(CC1)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 ZWCNNSKSVCPUJA-UHFFFAOYSA-N 0.000 claims 1
- HOAWBWSFBCVEPD-UHFFFAOYSA-N 5-[7-(1-methyl-2-oxospiro[indole-3,4'-piperidine]-1'-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C12=CC=CC=C2N(C)C(=O)C1(CC1)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 HOAWBWSFBCVEPD-UHFFFAOYSA-N 0.000 claims 1
- ZJCDXXKELHIWCK-UHFFFAOYSA-N 5-[7-(2,3-dihydro-1h-inden-2-ylcarbamoyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3CC4=CC=CC=C4C3)=CC=C2N=C1C1=CC=C(F)C=C1 ZJCDXXKELHIWCK-UHFFFAOYSA-N 0.000 claims 1
- RGMGIFZNJGLXPQ-UHFFFAOYSA-N 5-[7-(2,3-dihydro-1h-inden-2-ylcarbamoyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3CC4=CC=CC=C4C3)=CC=C2N=C1C1=CC=CC=C1 RGMGIFZNJGLXPQ-UHFFFAOYSA-N 0.000 claims 1
- MLWSTWZVJCDQAQ-UHFFFAOYSA-N 5-[7-(3,4-dihydro-1h-isoquinoline-2-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC4=CC=CC=C4CC3)=CC=C2N=C1C1=CC=CC=C1 MLWSTWZVJCDQAQ-UHFFFAOYSA-N 0.000 claims 1
- QDDQJOCJWWBNMJ-UHFFFAOYSA-N 5-[7-(3-benzylpiperazine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC=4C=CC=CC=4)NCC3)=CC=C2N=C1C1=CC=CC=C1 QDDQJOCJWWBNMJ-UHFFFAOYSA-N 0.000 claims 1
- AWMPEFQYUPAEQI-UHFFFAOYSA-N 5-[7-(3-benzylpyrrolidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC=4C=CC=CC=4)CC3)=CC=C2N=C1C1=CC=CC=C1 AWMPEFQYUPAEQI-UHFFFAOYSA-N 0.000 claims 1
- VKSWIICHIWOAIB-UHFFFAOYSA-N 5-[7-(4-cyano-4-phenylpiperidine-1-carbonyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)(C#N)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 VKSWIICHIWOAIB-UHFFFAOYSA-N 0.000 claims 1
- JDFZUZAKKJFJKW-UHFFFAOYSA-N 5-[7-(4-cyano-4-phenylpiperidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)(C#N)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 JDFZUZAKKJFJKW-UHFFFAOYSA-N 0.000 claims 1
- YMBWQAFAJNDGQI-UHFFFAOYSA-N 5-[7-(4-imidazol-1-ylpiperidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)N3C=NC=C3)=CC=C2N=C1C1=CC=CC=C1 YMBWQAFAJNDGQI-UHFFFAOYSA-N 0.000 claims 1
- OEDWUCKOVMARFK-UHFFFAOYSA-N 5-[7-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C(NCN4C=3C=CC=CC=3)=O)=CC=C2N=C1C1=CC=CC=C1 OEDWUCKOVMARFK-UHFFFAOYSA-N 0.000 claims 1
- VCKLCJYSERWIHF-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethoxy)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(OC(F)(F)F)C=C1 VCKLCJYSERWIHF-UHFFFAOYSA-N 0.000 claims 1
- CHZJMLXIKUQROY-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethyl)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)C=C1 CHZJMLXIKUQROY-UHFFFAOYSA-N 0.000 claims 1
- RRHZADFQWIIGBR-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[6-(trifluoromethyl)pyridin-3-yl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)N=C1 RRHZADFQWIIGBR-UHFFFAOYSA-N 0.000 claims 1
- BYGYLTLVEPIAHT-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-thiophen-3-ylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C=1C=CSC=1 BYGYLTLVEPIAHT-UHFFFAOYSA-N 0.000 claims 1
- ULBQWOQDFKIDJN-UHFFFAOYSA-N 5-[7-(benzylcarbamoyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 ULBQWOQDFKIDJN-UHFFFAOYSA-N 0.000 claims 1
- QKNBLHUZSNWVTN-UHFFFAOYSA-N 5-[7-(benzylcarbamoyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 QKNBLHUZSNWVTN-UHFFFAOYSA-N 0.000 claims 1
- VKCLRVKVWDKNCM-UHFFFAOYSA-N 5-[7-[(2-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C(=CC=CC=3)F)=CC=C2N=C1C1=CC=CC=C1 VKCLRVKVWDKNCM-UHFFFAOYSA-N 0.000 claims 1
- QIHQTMUJJIJNFW-JOCHJYFZSA-N 5-[7-[(2r)-2-methyl-4-phenylpiperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C([C@H]1C)N(C=2C=CC=CC=2)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 QIHQTMUJJIJNFW-JOCHJYFZSA-N 0.000 claims 1
- WNGHTDLFIMLLAI-OAQYLSRUSA-N 5-[7-[(2r)-4-(4-fluorophenyl)-2-methylpiperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C([C@H]1C)N(C=2C=CC(F)=CC=2)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WNGHTDLFIMLLAI-OAQYLSRUSA-N 0.000 claims 1
- RCYADRFEIAPNSV-UHFFFAOYSA-N 5-[7-[(3-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=C(F)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 RCYADRFEIAPNSV-UHFFFAOYSA-N 0.000 claims 1
- KFRYMDDHJNIIFZ-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 KFRYMDDHJNIIFZ-UHFFFAOYSA-N 0.000 claims 1
- GQZQTFRCGJPXJP-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CN=C2N=C1C1=CC=CC=C1 GQZQTFRCGJPXJP-UHFFFAOYSA-N 0.000 claims 1
- UAVCNEZPCLYWBG-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=CC=C1 UAVCNEZPCLYWBG-UHFFFAOYSA-N 0.000 claims 1
- GGNVXMSXWYYGCH-UHFFFAOYSA-N 5-[7-[(4-chloropyridin-2-yl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=CC=C(Cl)C=3)=CC=C2N=C1C1=CC=CC=C1 GGNVXMSXWYYGCH-UHFFFAOYSA-N 0.000 claims 1
- QGRPUHUSFNWTSJ-UHFFFAOYSA-N 5-[7-[(4-ethylphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(CC)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 QGRPUHUSFNWTSJ-UHFFFAOYSA-N 0.000 claims 1
- CLCWAYCFHGUBDC-UHFFFAOYSA-N 5-[7-[(4-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 CLCWAYCFHGUBDC-UHFFFAOYSA-N 0.000 claims 1
- BWXPIFSNZHHPQD-UHFFFAOYSA-N 5-[7-[(4-methoxyphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 BWXPIFSNZHHPQD-UHFFFAOYSA-N 0.000 claims 1
- KOGDXAWCAXRPDB-UHFFFAOYSA-N 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 KOGDXAWCAXRPDB-UHFFFAOYSA-N 0.000 claims 1
- DFMDDIZIKNIOPL-UHFFFAOYSA-N 5-[7-[(6-chloropyridin-2-yl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 DFMDDIZIKNIOPL-UHFFFAOYSA-N 0.000 claims 1
- QEVGUIZQYFGYKB-UHFFFAOYSA-N 5-[7-[1-(2-fluorophenyl)ethylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C=1C=CC=C(F)C=1C(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 QEVGUIZQYFGYKB-UHFFFAOYSA-N 0.000 claims 1
- HHGIVZJUTSQELQ-UHFFFAOYSA-N 5-[7-[1-(4-methoxyphenyl)ethylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C(C)NC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 HHGIVZJUTSQELQ-UHFFFAOYSA-N 0.000 claims 1
- CVDOIYDXAAAWSL-UHFFFAOYSA-N 5-[7-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCCCN3C(CCC3)=O)=CC=C2N=C1C1=CC=CC=C1 CVDOIYDXAAAWSL-UHFFFAOYSA-N 0.000 claims 1
- BWNMSYYOIRKIFH-UHFFFAOYSA-N 5-[7-[3-(3-chlorophenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 BWNMSYYOIRKIFH-UHFFFAOYSA-N 0.000 claims 1
- QXKMQSCXFNWKDZ-UHFFFAOYSA-N 5-[7-[3-(3-fluorophenyl)azetidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=C(F)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 QXKMQSCXFNWKDZ-UHFFFAOYSA-N 0.000 claims 1
- SDSWTMZIIDPXCU-UHFFFAOYSA-N 5-[7-[3-(4-cyanophenyl)azetidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=CC=C1 SDSWTMZIIDPXCU-UHFFFAOYSA-N 0.000 claims 1
- OSQSIEZTHIYWEA-UHFFFAOYSA-N 5-[7-[3-(4-fluorophenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 OSQSIEZTHIYWEA-UHFFFAOYSA-N 0.000 claims 1
- JFRGYUBQVPKGJY-UHFFFAOYSA-N 5-[7-[3-(4-methoxyphenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C1CN(C(=O)C=2C=C3N=C(CCCCC(O)=O)C(=NC3=CC=2)C=2C=CC=CC=2)CC1 JFRGYUBQVPKGJY-UHFFFAOYSA-N 0.000 claims 1
- YITYUAONQFEKPF-UHFFFAOYSA-N 5-[7-[4-(2-oxo-3h-benzimidazol-1-yl)piperidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)N3C(NC4=CC=CC=C43)=O)=CC=C2N=C1C1=CC=CC=C1 YITYUAONQFEKPF-UHFFFAOYSA-N 0.000 claims 1
- WRBRIPORLVOATP-UHFFFAOYSA-N 5-[7-[4-(4-chlorophenyl)-3,6-dihydro-2h-pyridine-1-carbonyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC=C(CC3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 WRBRIPORLVOATP-UHFFFAOYSA-N 0.000 claims 1
- GPQHXXZGLWYWIP-UHFFFAOYSA-N 5-[7-[4-(4-chlorophenyl)piperidine-1-carbonyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 GPQHXXZGLWYWIP-UHFFFAOYSA-N 0.000 claims 1
- AEGIBEQQHNAMTN-QGZVFWFLSA-N 5-[7-[[(1r)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 AEGIBEQQHNAMTN-QGZVFWFLSA-N 0.000 claims 1
- WYJYYDFUZDCDME-GOSISDBHSA-N 5-[7-[[(1r)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WYJYYDFUZDCDME-GOSISDBHSA-N 0.000 claims 1
- PBWZNRGCNJVWMK-GOSISDBHSA-N 5-[7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 PBWZNRGCNJVWMK-GOSISDBHSA-N 0.000 claims 1
- MSJNIEVSJHMXEZ-HXUWFJFHSA-N 5-[7-[[(1r)-1-(4-methylphenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(C)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 MSJNIEVSJHMXEZ-HXUWFJFHSA-N 0.000 claims 1
- YDBRFEIDFKPSRE-FZYLFJGDSA-N 5-[7-[[(1r)-5-fluoro-2,3-dihydro-1h-inden-1-yl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=C(F)C=C4CC3)=CC=C2N=C1C1=CC=C(F)C=C1 YDBRFEIDFKPSRE-FZYLFJGDSA-N 0.000 claims 1
- AEGIBEQQHNAMTN-KRWDZBQOSA-N 5-[7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 AEGIBEQQHNAMTN-KRWDZBQOSA-N 0.000 claims 1
- WYJYYDFUZDCDME-SFHVURJKSA-N 5-[7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WYJYYDFUZDCDME-SFHVURJKSA-N 0.000 claims 1
- PBWZNRGCNJVWMK-SFHVURJKSA-N 5-[7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 PBWZNRGCNJVWMK-SFHVURJKSA-N 0.000 claims 1
- MSJNIEVSJHMXEZ-FQEVSTJZSA-N 5-[7-[[(1s)-1-(4-methylphenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(C)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 MSJNIEVSJHMXEZ-FQEVSTJZSA-N 0.000 claims 1
- SFHUNRZWMRGQLN-JOCHJYFZSA-N 5-[7-[[(4r)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=C(F)C=C1 SFHUNRZWMRGQLN-JOCHJYFZSA-N 0.000 claims 1
- WJFZTWDZOSEIKT-JOCHJYFZSA-N 5-[7-[[(4r)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=CC=C1 WJFZTWDZOSEIKT-JOCHJYFZSA-N 0.000 claims 1
- DCVFUNKZYSYNDY-UHFFFAOYSA-N 5-[7-[benzyl(methyl)carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C=1C=C2N=C(C=3C=CC=CC=3)C(CCCCC(O)=O)=NC2=CC=1C(=O)N(C)CC1=CC=CC=C1 DCVFUNKZYSYNDY-UHFFFAOYSA-N 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- NTXXEMIBCMIRFZ-UHFFFAOYSA-N CC1=CN=NN1C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 Chemical compound CC1=CN=NN1C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 NTXXEMIBCMIRFZ-UHFFFAOYSA-N 0.000 claims 1
- DPPWQRCRYSCVHC-UHFFFAOYSA-N CC=1N=NN(C1)C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 Chemical compound CC=1N=NN(C1)C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 DPPWQRCRYSCVHC-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 208000027744 congestion Diseases 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 claims 1
- 229960003424 phenylacetic acid Drugs 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426886P | 2010-12-23 | 2010-12-23 | |
| US61/426,886 | 2010-12-23 | ||
| PCT/US2011/065716 WO2012087861A1 (en) | 2010-12-23 | 2011-12-19 | Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500323A JP2014500323A (ja) | 2014-01-09 |
| JP2014500323A5 true JP2014500323A5 (https=) | 2015-03-12 |
| JP5952829B2 JP5952829B2 (ja) | 2016-07-13 |
Family
ID=46314391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546270A Expired - Fee Related JP5952829B2 (ja) | 2010-12-23 | 2011-12-19 | Ｃｒｔｈ２受容体調節剤としてのキノキサリン類およびアザ−キノキサリン類 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9469615B2 (https=) |
| EP (1) | EP2661428B1 (https=) |
| JP (1) | JP5952829B2 (https=) |
| KR (1) | KR20130133219A (https=) |
| CN (1) | CN103702985B (https=) |
| AR (1) | AR084573A1 (https=) |
| AU (1) | AU2011349524B2 (https=) |
| BR (1) | BR112013015397A2 (https=) |
| CA (1) | CA2818597A1 (https=) |
| ES (1) | ES2635030T3 (https=) |
| MX (1) | MX2013007295A (https=) |
| RU (1) | RU2589709C2 (https=) |
| TW (1) | TW201307302A (https=) |
| WO (1) | WO2012087861A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012500382A1 (en) | 2009-09-03 | 2012-10-22 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| EP2590944B1 (en) | 2010-07-05 | 2015-09-30 | Actelion Pharmaceuticals Ltd. | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| EP2627178B1 (en) | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
| US9290453B2 (en) | 2010-12-23 | 2016-03-22 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as CRTH2 receptor modulators |
| BR112013022147A2 (pt) * | 2011-03-02 | 2017-04-25 | Bioenergenix | composto, composição farmacêutica, método de inibição da pask, método de tratamento de uma doença, método para alcançar um efeito em um paciente e método de tratamento de uma doença mediada pela pask |
| PH12013502619A1 (en) | 2011-06-17 | 2014-02-17 | Merck Sharp & Dohme | Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
| JP6097765B2 (ja) | 2011-12-21 | 2017-03-15 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ヘテロシクリル誘導体及びプロスタグランジンｄ２受容体調節剤としてのそれらの使用 |
| MX361539B (es) | 2012-04-25 | 2018-12-10 | Takeda Pharmaceuticals Co | Compuesto heterociclico nitrogenado. |
| WO2014006585A1 (en) | 2012-07-05 | 2014-01-09 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| EP2873669A4 (en) | 2012-07-13 | 2015-11-25 | Takeda Pharmaceutical | HETEROCYCLIC CONNECTION |
| EP2922539B1 (en) | 2012-10-01 | 2020-01-15 | Merck Sharp & Dohme Corp. | Substituted isoquinolines as crth2 receptor modulators |
| JP2016507538A (ja) | 2013-02-07 | 2016-03-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 置換キノキサリン誘導体およびｍＧｌｕＲ４の正のアロステリックモジュレーターとしてのそれらの使用 |
| EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP6427491B2 (ja) | 2013-07-03 | 2018-11-21 | 武田薬品工業株式会社 | 複素環化合物 |
| ES2950424T3 (es) | 2013-07-03 | 2023-10-09 | Takeda Pharmaceuticals Co | Compuesto de amida |
| JPWO2015012328A1 (ja) | 2013-07-24 | 2017-03-02 | 武田薬品工業株式会社 | 複素環化合物 |
| US10160756B2 (en) | 2014-03-31 | 2018-12-25 | The Trustees Of The University Of Pennsylvania | Antiviral compounds and methods using same |
| US10144742B2 (en) | 2014-04-18 | 2018-12-04 | Millennium Pharmaceuticals, Inc. | Quinoxaline compounds and uses thereof |
| EP3247705B1 (en) | 2015-01-20 | 2019-11-20 | Millennium Pharmaceuticals, Inc. | Quinazoline and quinoline compounds and uses thereof as nampt inhibitors |
| US11541046B2 (en) * | 2017-06-30 | 2023-01-03 | Quixgen, Inc. | Spirolactone compounds |
| JP2020525472A (ja) * | 2017-06-30 | 2020-08-27 | ライブ・セラピューティクス・スプウカ・アクツィーナＲｙｖｕ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓ．Ａ． | アデノシンａ２ａ受容体のイミダゾ［１，２−ａ］ピラジン調節剤 |
| EP3643711A1 (en) | 2018-10-24 | 2020-04-29 | Bayer Animal Health GmbH | New anthelmintic compounds |
| JP7589247B2 (ja) * | 2019-12-17 | 2024-11-25 | メルク・シャープ・アンド・ドーム・エルエルシー | Ｐｒｍｔ５阻害剤 |
| US12595248B2 (en) | 2019-12-17 | 2026-04-07 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| CN115003303B (zh) * | 2019-12-17 | 2024-03-08 | 默沙东公司 | Prmt5抑制剂 |
| EP4076460B1 (en) * | 2019-12-17 | 2026-01-21 | Merck Sharp & Dohme LLC | 1,4-dihydro-2h-spiro[isoquinoline-3,4'-piperidine derivatives as prmt5 inhibitors for the treatment of cancer |
| CN110981820B (zh) * | 2019-12-25 | 2023-05-19 | 上海彩迩文生化科技有限公司 | 一种酸性条件下合成喹喔啉-2-酮的方法 |
| WO2024036288A2 (en) * | 2022-08-11 | 2024-02-15 | Maplight Therapeutics, Inc. | Gpr6 inverse agonists |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3076672B2 (ja) | 1992-06-18 | 2000-08-14 | 三井化学株式会社 | キノリン誘導体のフマル酸塩 |
| WO1995015973A1 (en) | 1993-12-06 | 1995-06-15 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
| US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| WO1996001644A1 (en) | 1994-07-11 | 1996-01-25 | Athena Neurosciences, Inc. | Inhibitors of leukocyte adhesion |
| US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| GB9524630D0 (en) | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| WO1996031206A2 (en) | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
| WO1996040781A1 (en) | 1995-06-07 | 1996-12-19 | Tanabe Seiyaku Co., Ltd. | CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION |
| AU6311996A (en) | 1995-07-06 | 1997-02-05 | Zeneca Limited | Peptide inhibitors of fibronectine |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| DE10013318A1 (de) * | 2000-03-17 | 2001-09-20 | Merck Patent Gmbh | Formulierung enthaltend Chinoxalinderivate |
| GB0023918D0 (en) | 2000-09-29 | 2000-11-15 | King S College London | Antiparasitic compounds |
| CA2425440C (en) | 2000-10-12 | 2010-04-13 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| DE60304726T2 (de) | 2002-07-19 | 2007-08-09 | Winston Pharmaceuticals Llc, Newport Beach | Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer |
| EP1556356B1 (en) * | 2002-10-21 | 2006-05-31 | Warner-Lambert Company LLC | Tetrahydroquinoline derivatives as crth2 antagonists |
| BRPI0412590A (pt) | 2003-07-15 | 2006-09-19 | Allergan Inc | processo para preparação de pró-drogas isomericamente puras de inibidores de bomba de próton |
| GB0324763D0 (en) * | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| MY144903A (en) * | 2004-06-17 | 2011-11-30 | Novartis Ag | Pyrrolopyridine derivatives and their use as crth2 antagonists |
| CA2603345C (en) | 2005-04-01 | 2017-05-02 | Insa Rouen | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| ES2443022T3 (es) | 2005-08-12 | 2014-02-17 | Merck Frosst Canada Inc. | Derivados de indol como antagonistas del receptor CRTH2 |
| EP1968968A1 (en) | 2005-12-21 | 2008-09-17 | PainCeptor Pharma Corp. | Compositions and methods for modulating gated ion channels |
| AR059733A1 (es) | 2006-03-07 | 2008-04-23 | Smithkline Beecham Corp | Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion |
| WO2007138112A2 (en) | 2006-06-01 | 2007-12-06 | Devgen N.V. | Compounds that interact with ion channels, in particular with ion channels from the kv family |
| MX2009010376A (es) * | 2007-03-29 | 2010-01-20 | Argenta Oral Therapeutics Ltd | Derivados de quinolina como ligandos del receptor crth2. |
| GB0722203D0 (en) * | 2007-11-13 | 2007-12-19 | Oxagen Ltd | Use of CRTH2 antagonist compounds |
| EP2346865B1 (en) | 2008-09-22 | 2015-07-15 | Merck Canada Inc. | Indole derivatives as crth2 receptor antagonists |
| AU2009295229B2 (en) | 2008-09-22 | 2014-02-27 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
| AU2009295231A1 (en) | 2008-09-22 | 2010-03-25 | Merck Canada Inc. | Azaindole derivatives as CRTH2 receptor antagonists |
| CA2747795A1 (en) * | 2008-12-25 | 2010-07-01 | Taisho Pharmaceutical Co., Ltd. | Isoquinoline derivative |
| PE20120056A1 (es) | 2009-02-24 | 2012-02-05 | Merck Sharp & Dohme | Derivados de indol como antagonistas del receptor crth2 |
| PH12012500382A1 (en) | 2009-09-03 | 2012-10-22 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| EP2627178B1 (en) | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
| US9290453B2 (en) | 2010-12-23 | 2016-03-22 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as CRTH2 receptor modulators |
| PH12013502619A1 (en) | 2011-06-17 | 2014-02-17 | Merck Sharp & Dohme | Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
-
2011
- 2011-12-19 EP EP11851281.3A patent/EP2661428B1/en active Active
- 2011-12-19 MX MX2013007295A patent/MX2013007295A/es not_active Application Discontinuation
- 2011-12-19 JP JP2013546270A patent/JP5952829B2/ja not_active Expired - Fee Related
- 2011-12-19 BR BR112013015397A patent/BR112013015397A2/pt not_active Application Discontinuation
- 2011-12-19 CA CA2818597A patent/CA2818597A1/en not_active Abandoned
- 2011-12-19 RU RU2013134334/04A patent/RU2589709C2/ru not_active IP Right Cessation
- 2011-12-19 AU AU2011349524A patent/AU2011349524B2/en not_active Ceased
- 2011-12-19 WO PCT/US2011/065716 patent/WO2012087861A1/en not_active Ceased
- 2011-12-19 ES ES11851281.3T patent/ES2635030T3/es active Active
- 2011-12-19 CN CN201180062255.5A patent/CN103702985B/zh not_active Expired - Fee Related
- 2011-12-19 KR KR1020137016245A patent/KR20130133219A/ko not_active Ceased
- 2011-12-19 US US13/996,361 patent/US9469615B2/en active Active
- 2011-12-21 TW TW100147844A patent/TW201307302A/zh unknown
- 2011-12-22 AR ARP110104895A patent/AR084573A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014500323A5 (https=) | ||
| RU2013134334A (ru) | Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2 | |
| JP5202954B2 (ja) | ラクタム化合物およびその医薬としての使用 | |
| KR101415861B1 (ko) | 락탐 화합물 및 이를 사용하는 방법 | |
| JP6382108B2 (ja) | 新規二環式ジヒドロイソキノリン−１−オン誘導体 | |
| KR20160030983A (ko) | 이온 채널의 조절제로서의 융합된 피페리딘 아미드 | |
| KR20080098070A (ko) | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 | |
| US7786308B2 (en) | Muscarinic modulators | |
| AU2006330866A1 (en) | Modulators of muscarinic receptors | |
| JP2006503010A5 (https=) | ||
| EA001374B1 (ru) | Производные 1-(1,2-дизамещенный пиперидинил)-4-(конденсированный имидазол)-пиперидина | |
| CN103958478A (zh) | 新双环二氢异喹啉-1-酮衍生物 | |
| EP1817036B1 (en) | Modulators of muscarinic receptors | |
| ZA200609236B (en) | Amido compounds and their use as pharmaceuticals | |
| EP4615824A1 (en) | Substituted quinolone compounds useful as inhibitors of tlr9 | |
| ZA200604543B (en) | Heterocyclic anti-migraine agents | |
| CN101098856A (zh) | 内酰胺化合物及其作为药物的应用 | |
| EA039638B1 (ru) | Антагонисты мускаринового рецептора 4 и способы их применения | |
| AU2012211350A1 (en) | Lactam compounds and their use as pharmaceuticals | |
| HK1195302A (en) | Bicyclic dihydroisoquinoline-1-one derivatives | |
| CN101479266A (zh) | 作为毒蕈碱受体调节剂的螺稠合哌啶 |